CTI Investigational Site 10003 — Greenville, South Carolina

CTI Investigational Site 10003 is a clinical research site located in Greenville, South Carolina, United States 29601.

Crixeo Health Trust Score: 46/100 (POOR). This profile has not yet been claimed by the site owner.

CTI Investigational Site 10003 has participated in 1 clinical trials.

Therapeutic areas: Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis.

Sponsors: CTI BioPharma.

Sponsor Feasibility Report

Trust Score: 46/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for CTI Investigational Site 10003?

CTI Investigational Site 10003 has a Crixeo Trust Score of 46/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has CTI Investigational Site 10003 conducted?

CTI Investigational Site 10003 has 1 clinical trials on record. Their work covers Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis.

Is CTI Investigational Site 10003 accredited by Crixeo Health?

CTI Investigational Site 10003 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about CTI Investigational Site 10003?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.